PMID- 29738391 OWN - NLM STAT- MEDLINE DCOM- 20191009 LR - 20191010 IS - 1537-4505 (Electronic) IS - 1531-7129 (Linking) VI - 39 IP - 5 DP - 2018 Jun TI - Comparison of Clinical Characteristics and Surgical Outcomes of Cystic and Solid Vestibular Schwannomas. PG - e381-e386 LID - 10.1097/MAO.0000000000001813 [doi] AB - OBJECTIVE: The aim of this study was to compare the clinical characteristics of cystic vestibular schwannomas (CVSs) and solid vestibular schwannomas (SVSs). STUDY DESIGN: Retrospective review. SETTING: Tertiary care center. PATIENTS: A total of 220 patients who underwent microsurgery for vestibular schwannomas between 2007 and 2016. INTERVENTION: CVSs were defined as cystic components >/=1/3 of total tumor volume based on automated volume measurement. Tumors larger than 5 cm were defined as large tumors. MAIN OUTCOME MEASURES: Clinical characteristics and surgical outcomes, including preoperative symptoms, hearing threshold, vestibular function, tumor volume, extent of resection, facial nerve outcomes, and nonfacial complications were evaluated. RESULTS: Tumor volume was significantly larger in CVSs (20.44 +/- 13.85 cm in CVSs; 4.75 +/- 6.48 cm in SVSs, p < 0.001) and the proportion of larger tumors was also greater in CVSs (66.0% in CVSs; 11.4% in SVSs, p < 0.001). Preoperative dizziness was highly prevalent in CVSs (32.1% in CVSs; 18.6% in SVSs, p = 0.038) and postoperative facial nerve outcomes were significantly worse in CVSs (67.9% favorable rate in CVSs; 87.4% favorable rate in SVSs, p = 0.001). When the comparison was limited to large tumors, no clinical characteristics or surgical outcomes were significantly different. Tumor volume had a greater effect than tumor type on the surgical outcomes. The odds ratios for subtotal resection and unfavorable facial nerve function with a large tumor were 5.77 (confidence interval [CI]: 1.52-21.95, p = 0.010) and 5.34 (CI: 1.41-20.22, p = 0.014), respectively. CONCLUSION: CVSs tend to be larger than SVSs. Tumor volume, not cystic component, is thought to be a major determinant of surgical outcomes. FAU - Han, Ji Hyuk AU - Han JH AD - Department of Otorhinolaryngology, Yonsei University College of Medicine, Seoul. FAU - Baek, Kwang Ha AU - Baek KH AD - Department of Otorhinolaryngology, Yonsei University College of Medicine, Seoul. FAU - Lee, Young Woo AU - Lee YW AD - Department of Otorhinolaryngology, Yonsei University College of Medicine, Seoul. FAU - Hur, Young Kyun AU - Hur YK AD - Department of Otorhinolaryngology, Yonsei University College of Medicine, Seoul. FAU - Kim, Hyun Ji AU - Kim HJ AD - Department of Otorhinolaryngology-Head and Neck Surgery, Inha University College of Medicine, Incheon, Korea. FAU - Moon, In Seok AU - Moon IS AD - Department of Otorhinolaryngology, Yonsei University College of Medicine, Seoul. LA - eng PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Otol Neurotol JT - Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology JID - 100961504 SB - IM MH - Adult MH - Aged MH - Female MH - Follow-Up Studies MH - Humans MH - Male MH - Middle Aged MH - Neuroma, Acoustic/*pathology/*surgery MH - Neurosurgical Procedures/*adverse effects MH - Postoperative Complications/epidemiology/*etiology MH - Retrospective Studies MH - Treatment Outcome EDAT- 2018/05/09 06:00 MHDA- 2019/10/11 06:00 CRDT- 2018/05/09 06:00 PHST- 2018/05/09 06:00 [entrez] PHST- 2018/05/09 06:00 [pubmed] PHST- 2019/10/11 06:00 [medline] AID - 00129492-201806000-00032 [pii] AID - 10.1097/MAO.0000000000001813 [doi] PST - ppublish SO - Otol Neurotol. 2018 Jun;39(5):e381-e386. doi: 10.1097/MAO.0000000000001813.